Sean Bohen just wrote the handbook on how to make a quick fortune in biotech
If you ask anyone in drug development about what motivates them — or even if you don’t — you’re going to get a regular double-barreled blast about patients and unmet medical needs if you’re covering this industry. Less discussed and just as important during a heady IPO boom is a shot at the overnight fortunes that are on offer in the middle of a pandemic.
Sean Bohen’s team at Olema just spelled it all out in an S-1 that can serve as a compactly written handbook on the subject — provided you know the background.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.